Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Paragon 28 Inc FNA

Paragon 28, Inc. is a medical device company focused on the foot and ankle orthopedic market. The Company provides orthopedic solutions, procedural approaches and instrumentation that cover a range of foot and ankle ailments, including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. To treat these painful... see more

Recent & Breaking News (NYSE:FNA)

Paragon 28 to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

Business Wire August 28, 2023

Paragon 28 Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance

Business Wire August 2, 2023

Paragon 28 to Present at the Canaccord Genuity 43rd Annual Growth Conference

Business Wire July 28, 2023

Paragon 28 To Report Second Quarter Financial Results on August 2, 2023

Business Wire July 12, 2023

Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System

Business Wire May 23, 2023

Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance

Business Wire May 4, 2023

Paragon 28 to Present at the Bank of America Securities 2023 Healthcare Conference

Business Wire April 26, 2023

Paragon 28 Launches Phantom® Metatarsal Shortening System

Business Wire April 24, 2023

Paragon 28 To Report First Quarter Financial Results on May 4, 2023

Business Wire April 20, 2023

Paragon 28 Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance

Business Wire March 2, 2023

Paragon 28 to Present at Upcoming Investor Conferences

Business Wire March 1, 2023

Paragon 28, Inc. Announces Closing of Underwriters' Option to Purchase Additional Shares in Connection with Public Offering of Common Stock

Business Wire February 17, 2023

Paragon 28 To Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

Business Wire February 16, 2023

Paragon 28, Inc. Announces Pricing of Public Offering

Business Wire January 25, 2023

Paragon 28, Inc. Announces Proposed Public Offering of Common Stock

Business Wire January 25, 2023

Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022

Business Wire January 10, 2023

Paragon 28 to Present at The 34th Annual Piper Sandler Healthcare Conference

Business Wire November 16, 2022

Paragon 28 Reports Third Quarter 2022 Financial Results and Increases 2022 Net Revenue Guidance

Business Wire November 10, 2022

Paragon 28 To Report Third Quarter 2022 Financial Results on November 10, 2022

Business Wire October 27, 2022

Paragon 28 to Present at The Morgan Stanley 20th Annual Global Healthcare Conference

Business Wire August 25, 2022